Biomarkers Industry Register Sensational CAGR
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
3.1.Introduction<br />
3.1.1.<strong>Industry</strong> Definition<br />
3.1.2.<strong>Industry</strong> Segmentation<br />
3.2.<strong>Industry</strong> Dynamics<br />
3.2.1.Drivers<br />
…<br />
Chapter 4. <strong>Industry</strong> Analysis by Regions<br />
4.1.North America (United States, Canada and Mexico)<br />
4.1.1.United States <strong>Industry</strong> States and Outlook (2014-2023)<br />
4.1.2.Canada <strong>Industry</strong> States and Outlook (2014-2023)<br />
4.1.3.Mexico <strong>Industry</strong> States and Outlook (2014-2023)<br />
4.2.Europe (Germany, France, UK, Russia, Italy and Rest of Europe)<br />
4.2.1.Germany <strong>Industry</strong> States and Outlook (2014-2023)<br />
4.2.2.France <strong>Industry</strong> States and Outlook (2014-2023)<br />
4.2.3.UK <strong>Industry</strong> States and Outlook (2014-2023)<br />
4.2.4.Russia <strong>Industry</strong> States and Outlook (2014-2023)<br />
4.2.5.Italy <strong>Industry</strong> States and Outlook (2014-2023)<br />
4.2.6.Rest of Europe <strong>Industry</strong> States and Outlook (2014-2023)<br />
…<br />
Chapter 5. <strong>Biomarkers</strong> <strong>Industry</strong>, By Type<br />
5.1.Introduction<br />
5.2.Global <strong>Biomarkers</strong> Revenue and <strong>Industry</strong> Share by Type (2014-2018)<br />
5.2.1.Global <strong>Biomarkers</strong> Revenue and Revenue Share by Type (2014-2018)<br />
5.3.Safety<br />
5.3.1.Global Safety Revenue and Growth Rate (2014-2018)<br />
5.4.Validation<br />
…<br />
Chapter6. <strong>Biomarkers</strong> <strong>Industry</strong>, By Application<br />
6.1.Introduction<br />
6.2.Global <strong>Biomarkers</strong> Revenue and <strong>Industry</strong> Share by Application (2014-2018)<br />
6.2.1.Global <strong>Biomarkers</strong> Revenue and Revenue Share by Application (2014-2018)<br />
6.3.Diagnostic<br />
6.3.1.Global Diagnostic Revenue and Growth Rate (2014-2018)<br />
6.4.Drug Development<br />
Chapter7. <strong>Biomarkers</strong> <strong>Industry</strong>, By Disease<br />
7.1.Introduction<br />
7.2.Global <strong>Biomarkers</strong> Revenue and <strong>Industry</strong> Share by Disease (2014-2018)<br />
7.2.1.Global <strong>Biomarkers</strong> Revenue and Revenue Share by Disease (2014-2018)<br />
7.3.Oncology Diseases<br />
7.3.1.Global Oncology Diseases Revenue and Growth Rate (2014-2018)<br />
7.4.Immunological Disease<br />
Chapter8. <strong>Biomarkers</strong> <strong>Industry</strong>, By Region<br />
Chapter 9. Company Profiles<br />
9.1.Roche Diagnostics Ltd.<br />
9.1.1. Business Overview<br />
9.1.2. Type Portfolio
Change language